SG
GILD icon

StoneX Group’s Gilead Sciences GILD Stock Holding History

StoneX Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$351K Sell
2,518
-1,655
-40% -$232K 0.02% 518
2025
Q4 		$512K Sell
4,173
-127
-3% -$15.4K 0.02% 526
2025
Q3 		$477K Buy
4,300
+192
+5% +$21.8K 0.02% 558
2025
Q2 		$455K Sell
4,108
-1,568
-28% -$167K 0.02% 533
2025
Q1 		$636K Buy
5,676
+1,268
+29% +$131K 0.03% 409
2024
Q4 		$407K Sell
4,408
-2,134
-33% -$192K 0.02% 518
2024
Q3 		$549K Buy
6,542
+563
+9% +$43K 0.25% 113
2024
Q2 		$410K Sell
5,979
-696
-10% -$46.4K 0.19% 143
2024
Q1 		$489K Buy
+6,675
New +$513K 0.25% 101
2023
Q3 		– Sell
-9,933
Closed -$766K – 425
2023
Q2 		$766K Buy
+9,933
New +$792K 0.43% 56
2023
Q1 		– Sell
-7,533
Closed -$647K – 553
2022
Q4 		$647K Buy
+7,533
New +$597K 0.09% 175
2022
Q2 		– Sell
-4,737
Closed -$282K – 608
2022
Q1 		$282K Buy
4,737
+88
+2% +$5.63K 0.03% 433
2021
Q4 		$338K Buy
+4,649
New +$320K 0.04% 376
2021
Q3 		– Sell
-2,918
Closed -$201K – 483
2021
Q2 		$201K Buy
+2,918
New +$195K 0.03% 452
2018
Q4 		– Sell
-3,786
Closed -$292K – 216
2018
Q3 		$292K Buy
3,786
+146
+4% +$11K 0.22% 166
2018
Q2 		$258K Sell
3,640
-190
-5% -$13.4K 0.22% 179
2018
Q1 		$289K Buy
3,830
+103
+3% +$8.19K 0.28% 146
2017
Q4 		$267K Buy
3,727
+725
+24% +$55.1K 0.28% 150
2017
Q3 		$243K Sell
3,002
-12,676
-81% -$969K 0.3% 138
2017
Q2 		$1.11M Buy
+15,678
New +$1.04M 0.35% 101

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

StoneX Group's GILD Position: Q1 2026 in Review

StoneX Group reduced its Gilead Sciences (GILD) stake by 40% in Q1 2026, selling an estimated $232K and leaving 2,518 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #518.

StoneX Group first reported a position in GILD in Q2 2017 and has held it in 20 quarters since. The position peaked at $1.11M in Q2 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • StoneX Group held 2,518 shares of Gilead Sciences worth $351K as of Q1 2026.
  • StoneX Group sold 1,655 Gilead Sciences shares in Q1 2026, an estimated $232K.
  • Gilead Sciences made up 0.02% of StoneX Group's portfolio in Q1 2026, its #518 holding.
  • StoneX Group first reported a position in Gilead Sciences in Q2 2017 and has held it in 20 quarters since.
  • StoneX Group's Gilead Sciences position peaked at $1.11M in Q2 2017.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.